Masimo (MASI) EBITDA Margin Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -278.00 |
| Jan 3, 2026 | -165.00 |
| Sep 27, 2025 | 104.00 |
| Jun 28, 2025 | -328.00 |
| Mar 29, 2025 | -463.00 |
| Dec 28, 2024 | -4,395.00 |
| Sep 28, 2024 | -1,142.00 |
| Jun 29, 2024 | -1,046.00 |
| Mar 30, 2024 | -855.00 |
| Dec 30, 2023 | -5,702.00 |
| Sep 30, 2023 | -1,784.00 |
| Jul 1, 2023 | -1,297.00 |
| Apr 1, 2023 | -1,457.00 |
| Dec 31, 2022 | 25.00 |
| Oct 1, 2022 | -1,104.00 |
| Jul 2, 2022 | -2,076.00 |
| Apr 2, 2022 | -687.00 |
| Jan 1, 2022 | -14,580.00 |
| Oct 2, 2021 | 570.00 |
| Jul 3, 2021 | 465.00 |
| Apr 3, 2021 | 503.00 |
| Jan 2, 2021 | -6.00 |
| Sep 26, 2020 | 873.00 |
| Jun 27, 2020 | 787.00 |
| Mar 28, 2020 | 1,422.00 |
| Dec 28, 2019 | 1,341.00 |
| Sep 28, 2019 | 1,341.00 |
| Jun 29, 2019 | 1,408.00 |
| Mar 30, 2019 | 798.00 |
| Dec 29, 2018 | 1,792.00 |
| Sep 29, 2018 | 1,006.00 |
| Jun 30, 2018 | 760.00 |
| Mar 31, 2018 | 910.00 |
| Dec 30, 2017 | 978.00 |
| Sep 30, 2017 | 789.00 |
| Jul 1, 2017 | 996.00 |
| Apr 1, 2017 | 1,361.00 |
| Dec 31, 2016 | 15,715.00 |
| Oct 1, 2016 | 184.00 |
| Jul 2, 2016 | -351.00 |
| Apr 2, 2016 | 111.00 |
| Jan 2, 2016 | 161.00 |
| Oct 3, 2015 | -988.00 |
| Jul 4, 2015 | -819.00 |
| Apr 4, 2015 | -2,992.00 |
| Sep 27, 2014 | -1,470.00 |
| Jun 28, 2014 | -1,530.00 |